Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000555	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-11-02	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Certificate Issued	2020-12-07	view
JYSB2000554	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-11-02	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV	Certificate Issued	2020-12-07	view
JYSB2000551	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-10-29	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV	Certificate Issued	2020-12-07	view
JYSB2000550	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-10-29	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Certificate Issued	2020-12-07	view
JYSB2000465	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-09-17	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV	Filed	2020-09-29	view
JYSB2000464	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-09-17	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-09-29	view
JYSB2000462	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-09-17	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV	Filed	2020-09-29	view
JYSB2000461	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-09-17	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-09-29	view
JYSB2000275	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-06-22	view
JYSB2000274	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-06-22	view
JYSB2000273	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-06-22	view
JYSB2000272	精蛋白锌重组赖脯胰岛素混合注射液（25R）		Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-06-22	view
JYSB2000271	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV	Filed	2020-06-22	view
JYSB2000270	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-07-22	view
JYSB2000269	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-06-22	view
JYSB2000268	赖脯胰岛素注射液	insulin lispro	Injection	Biological Products	Supplementary Application	2020-06-18	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA	Filed	2020-06-22	view
JYSB2000243	依奇珠单抗注射液	ixekizumab	Injection	Biological Products	Supplementary Application	2020-06-10	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company	Filed	2020-06-19	view
JYSB2000240	Mirikizumab注射液	mirikizumab	Injection	Biological Products	Supplementary Application	2020-06-19	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company	In Review	2020-06-18	view
JYSB2000239	Mirikizumab注射液	mirikizumab	Injection	Biological Products	Supplementary Application	2020-06-19	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company	In Review	2020-06-18	view
JYSB2000238	Mirikizumab注射液	mirikizumab	Injection	Biological Products	Supplementary Application	2020-06-19	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company	In Review	2020-06-18	view